Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Brian Irving

Associate

Nashville
(615) 742-7769 TEL
(615) 248-4077 FAX

Brian Irving

Associate

Nashville
(615) 742-7769 TEL
(615) 248-4077 FAX
Nashville
(615) 742-7769 TEL
(615) 248-4077 FAX

As an associate in the firm's Litigation & Dispute Resolution Practice Group, Brian Irving counsels clients in complex business litigation matters, including business fraud, breach of contract disputes, shareholder litigation and securities fraud cases. He also represents clients in disputes related to compliance and defense of False Claims Act violations. Brian's clients span a variety of industries, including healthcare, pharmaceuticals and food services.

As an associate in the firm's Litigation & Dispute Resolution Practice Group, Brian Irving counsels clients in complex business litigation matters, including business fraud, breach of contract disputes, shareholder litigation and securities fraud cases. He also represents clients in disputes related to compliance and defense of False Claims Act violations. Brian's clients span a variety of industries, including healthcare, pharmaceuticals and food services.

Brian's practice includes:

  • Securities Fraud Investigations – representing corporate defendants facing Securities and Exchange Commission investigations and enforcement proceedings arising from alleged violations of federal securities laws, fraud and other matters that could lead to potential liability.
  • Healthcare Fraud & Abuse – representing healthcare providers in litigation matters brought under the False Claims Act and responding to government inquiries brought by the Office of the Inspector General of the Department of Health and Human Services, United States Attorneys' Offices and the Department of Justice.
Prior to joining Bass, Berry & Sims, Brian served as a law clerk to the Honorable Bobby E. Shepherd on the U.S. Court of Appeals for the Eighth Circuit. Brian earned his law degree from Vanderbilt Law School and received a B.A. in philosophy from Yale University. From 2008-2010, Brian played professional baseball with the San Francisco Giants organization.

+ Read More

- Read Less

News

View More

Publications

View More

Accolades

Vanderbilt Law Review – Articles Editor

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.